Washington Trust Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-93
Closed -$8.81K – 630
2025
Q3
$8.81K Hold
93
– – ﹤0.01% 541
2025
Q2
$9.74K Hold
93
– – ﹤0.01% 479
2025
Q1
$8.22K Hold
93
– – ﹤0.01% 492
2024
Q4
$8.92K Sell
93
-50
-35% -$4.66K ﹤0.01% 491
2024
Q3
$11.7K Hold
143
– – ﹤0.01% 460
2024
Q2
$12.3K Hold
143
– – ﹤0.01% 443
2024
Q1
$11.7K Hold
143
– – ﹤0.01% 457
2023
Q4
$9.48K Hold
143
– – ﹤0.01% 484
2023
Q3
$10.4K Hold
143
– – ﹤0.01% 455
2023
Q2
$9.03K Hold
143
– – ﹤0.01% 475
2023
Q1
$8.4K Hold
143
– – ﹤0.01% 526
2022
Q4
$8.81K Buy
143
+17
+13% +$1.14K ﹤0.01% 517
2022
Q3
$8K Hold
126
– – ﹤0.01% 635
2022
Q2
$8K Hold
126
– – ﹤0.01% 663
2022
Q1
$8K Hold
126
– – ﹤0.01% 737
2021
Q4
$6K Buy
+126
New +$7.34K ﹤0.01% 819

Other funds holding HQY

Washington Trust Advisors's HQY Position: Q4 2025 in Review

Washington Trust Advisors sold out of HealthEquity (HQY) in Q4 2025, closing a stake of 93 shares — an estimated $8.81K sold.

Washington Trust Advisors first reported a position in HQY in Q4 2021 and held it in 16 quarters. The position peaked at $12.3K in Q2 2024. 512 funds tracked by Wall St. Rank hold HQY as of Q4 2025.

  • Washington Trust Advisors reported no remaining HealthEquity position as of Q4 2025 after selling out during the quarter.
  • Washington Trust Advisors sold 93 HealthEquity shares in Q4 2025, an estimated $8.81K.
  • Washington Trust Advisors first reported a position in HealthEquity in Q4 2021 and held it in 16 quarters.
  • Washington Trust Advisors's HealthEquity position peaked at $12.3K in Q2 2024.
  • 512 funds tracked by Wall St. Rank held HealthEquity as of Q4 2025.

Based on Washington Trust Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.